FLT3LG and systemic lupus erythematosus: These studies have demonstrated a noteworthy correlation between FLT3LG and the incidence and therapeutic management of acute myeloid leukemia, rheumatoid arthritis, systemic lupus erythematosus, allergic asthma, and various other ailments [17, 25–29].